المؤلفون: Pan M; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Solozobova V; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Kuznik NC; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Jung N; Institute of Biological and Chemical Systems - Functional Molecular Systems, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Gräßle S; Institute of Biological and Chemical Systems - Functional Molecular Systems, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Gourain V; Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France., Heneka YM; Institute of Biological and Chemical Systems - Functional Molecular Systems, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Cramer von Clausbruch CA; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Fuhr O; Institute of Nanotechnology and Karlsruhe Nano Micro Facility (KNMFi), Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Munuganti RSN; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Maddalo D; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Blattner C; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Neeb A; Institute of Cancer Research, London, United Kingdom., Sharp A; Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Cato L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Weiss C; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Jeselsohn RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Orian-Rousseau V; Institute of Biological and Chemical Systems - Functional Molecular Systems, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany., Bräse S; Institute of Biological and Chemical Systems - Functional Molecular Systems, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany.; Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany., Cato ACB; Institute of Biological and Chemical Systems - Biological Information Processing, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany.

المصدر: Cancer research communications [Cancer Res Commun] 2023 Jul 27; Vol. 3 (7), pp. 1378-1396. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Estrogen Antagonists*/pharmacology, Female ; Humans ; Estrogen Receptor alpha/genetics ; Estrogens ; Receptors, Estrogen/genetics ; Tumor Suppressor Protein p53/genetics

المؤلفون: Wang M; Guizhou Medical University, Guiyang, Guizhou Province, People's Republic of China., Ye H

المصدر: The Journal of craniofacial surgery [J Craniofac Surg] 2023 May 01; Vol. 34 (3), pp. e304-e306. Date of Electronic Publication: 2023 Mar 15.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9010410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3732 (Electronic) Linking ISSN: 10492275 NLM ISO Abbreviation: J Craniofac Surg

مواضيع طبية MeSH: Cerebrospinal Fluid Rhinorrhea*/chemically induced , Cerebrospinal Fluid Rhinorrhea*/diagnosis , Cerebrospinal Fluid Rhinorrhea*/surgery , Breast Neoplasms*/drug therapy , Tamoxifen*/adverse effects , Tamoxifen*/therapeutic use , Estrogen Antagonists*/adverse effects , Estrogen Antagonists*/therapeutic use , Antineoplastic Agents, Hormonal*/adverse effects , Antineoplastic Agents, Hormonal*/therapeutic use , Bone Density*/drug effects, Humans ; Female ; Middle Aged ; Sphenoid Sinus/diagnostic imaging ; Sphenoid Sinus/pathology ; Tomography, X-Ray Computed

المؤلفون: Tamura K; Shimane University Hospital, Shimane, Japan., Mukohara T; National Cancer Center Hospital East, Kashiwa, Japan., Yonemori K; National Cancer Center Hospital, Tokyo, Japan., Kawabata Y; Sanofi, Tokyo, Japan., Nicolas X; Sanofi, Montpellier, France., Tanaka T; Sanofi, Tokyo, Japan., Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan. hiwata@aichi-cc.jp.

المصدر: Breast cancer (Tokyo, Japan) [Breast Cancer] 2023 May; Vol. 30 (3), pp. 506-517. Date of Electronic Publication: 2023 Mar 29.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Estrogen Antagonists*/administration & dosage , Estrogen Antagonists*/pharmacokinetics , Estrogen Antagonists*/therapeutic use, Female ; Humans ; East Asian People ; Maximum Tolerated Dose ; Receptors, Estrogen/genetics ; Genes, erbB-2/genetics ; Administration, Oral ; Selective Estrogen Receptor Modulators/administration & dosage ; Selective Estrogen Receptor Modulators/pharmacokinetics ; Selective Estrogen Receptor Modulators/therapeutic use

المؤلفون: Douglas E; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Levine B; Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Ansari A; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Ansley K; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Melin S; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Park CJ; Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Richardson K; Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Hatcher S; Division of Medical Oncology, Department of Internal Medicine, Duke University, Durham, NC, USA; Duke Cancer Institute, Duke University, Durham, NC, USA., D'Agostino RB Jr; Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Jordan JH; Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA, USA; Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA., Thomas A; Division of Medical Oncology, Department of Internal Medicine, Duke University, Durham, NC, USA; Duke Cancer Institute, Duke University, Durham, NC, USA. Electronic address: alexandra.thomas@duke.edu.

المصدر: Clinical breast cancer [Clin Breast Cancer] 2024 Jun; Vol. 24 (4), pp. e289-e296. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Premenopause* , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Referral and Consultation*/statistics & numerical data , Cardiovascular Diseases*, Humans ; Female ; Adult ; Middle Aged ; Retrospective Studies ; Estrogen Antagonists/therapeutic use ; Follow-Up Studies ; Receptors, Estrogen/metabolism ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/pathology

المؤلفون: Minko Essono S; Higher Teacher Training College, University of Bertoua, Bertoua, Cameroon., Mvondo MA; Research Unit of Animal Physiology and Phytopharmacology, University of Dschang, Dschang, Cameroon., Wego MTK; Research Unit of Animal Physiology and Phytopharmacology, University of Dschang, Dschang, Cameroon., Kemka Nguimatio FX; Research Unit of Animal Physiology and Phytopharmacology, University of Dschang, Dschang, Cameroon., Momo Tetsatsi AC; Faculty of Health Sciences, University of Bamenda, Bambili, Cameroon., Watcho P; Research Unit of Animal Physiology and Phytopharmacology, University of Dschang, Dschang, Cameroon.

المصدر: Journal of complementary & integrative medicine [J Complement Integr Med] 2024 Apr 26; Vol. 21 (2), pp. 175-183. Date of Electronic Publication: 2024 Apr 26 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Walter de Gruyter Country of Publication: Germany NLM ID: 101313855 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-3840 (Electronic) Linking ISSN: 15533840 NLM ISO Abbreviation: J Complement Integr Med Subsets: MEDLINE

مواضيع طبية MeSH: Rats, Wistar* , Plant Extracts*/pharmacology , Seeds*/chemistry , Uterus*/drug effects , Persea*/chemistry , Estradiol* , Vagina*/drug effects , Ovariectomy*, Animals ; Female ; Rats ; Estrogen Antagonists/pharmacology ; Ethanol ; Receptors, Estrogen/metabolism

المؤلفون: Xiong S; Jiangsu Key Laboratory of Drug Design and Optimization, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China., Song K; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China., Xiang H; Jiangsu Key Laboratory of Drug Design and Optimization, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: xianghua@cpu.edu.cn., Luo G; Jiangsu Key Laboratory of Drug Design and Optimization, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: gsluo@cpu.edu.cn.

المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 Apr 15; Vol. 270, pp. 116393. Date of Electronic Publication: 2024 Apr 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism, Humans ; Female ; Estrogen Receptor alpha/metabolism ; Receptors, Estrogen/metabolism ; Estrogen Antagonists/pharmacology ; Selective Estrogen Receptor Modulators/pharmacology ; Drug Resistance, Neoplasm

المؤلفون: Sarhan RM; Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. mhalkomy@ju.edu.sa., Salem SAM, Elkomy MH, Albuhayran RM, Hussein RRS, Boshra MS

المصدر: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2023 May; Vol. 27 (10), pp. 4583-4593.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Sildenafil Citrate*/administration & dosage , Sildenafil Citrate*/adverse effects , Sildenafil Citrate*/pharmacology , Endometrium*/diagnostic imaging , Endometrium*/drug effects , Infertility, Female*/drug therapy , Infertility, Female*/pathology , Clomiphene*/administration & dosage , Vasodilator Agents*/administration & dosage , Vasodilator Agents*/pharmacology , Estrogen Antagonists*/administration & dosage, Administration, Oral ; Drug Therapy, Combination ; Humans ; Female ; Adolescent ; Young Adult ; Adult ; Ovulation/drug effects ; Headache/chemically induced ; Ultrasonography ; Ovary/diagnostic imaging

المؤلفون: Crew KD; Columbia University Irving Medical Center, New York, NY, USA. Electronic address: kd59@cumc.columbia.edu., Anderson GL; SWOG Statistics and Data Management Center, Seattle, WA, USA., Arnold KB; SWOG Statistics and Data Management Center, Seattle, WA, USA., Stieb AP; Columbia University Irving Medical Center, New York, NY, USA., Amenta JN; Columbia University Irving Medical Center, New York, NY, USA., Collins N; Columbia University Irving Medical Center, New York, NY, USA., Law CW; Columbia University Irving Medical Center, New York, NY, USA., Pruthi S; Mayo Clinic, Rochester, MN, United States of America., Sandoval-Leon A; Miami Cancer Institute at Baptist Health South Florida, Miami, FL, USA., Bertoni D; Good Samaritan Hospital Corvallis, Corvallis, OR (rshirley@samhealth.org), USA., Grosse Perdekamp MT; Carle Cancer Center, Urbana, IL, USA., Colonna S; Huntsman Cancer Institute / University of Utah Medical Center, Salt Lake City, UT, USA., Krisher S; Holy Redeemer Hospital and Medical Center, Meadowbrook, PA, USA., King T; Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Boston, MA, USA., Yee LD; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Ballinger TJ; Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, USA., Braun-Inglis C; University of Hawaii Cancer Center, Honolulu, HI, USA., Mangino D; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wisinski KB; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., DeYoung CA; Kaiser Permanente NCORP, Vallejo, CA, USA., Ross M; Virginia Commonwealth University, Richmond, VA, USA., Floyd J; Cancer Care Specialists of Illinois, Heartland NCORP, Decatur, IL, USA., Kaster A; Sanford Roger Maris Cancer Center, Fargo, ND, United States of America., Vander Walde L; Baptist Memorial Health Care, Memphis, TN, United States of America., Saphner T; Aurora NCORP, Milwaukee, WI, USA., Zarwan C; Lahey Hospital & Medical Center, Burlington, MA, USA., Lo S; Loyola University Stritch School of Medicine, Maywood, IL, USA., Graham C; Emory University Hospital/Winship Cancer Institute, Atlanta, GA, USA., Conlin A; Providence Cancer Institute, Portland, OR, USA., Yost K; Cancer Research Consortium of West Michigan NCORP, Kalamazoo, MI, USA., Agnese D; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Jernigan C; SWOG Statistics and Data Management Center, Seattle, WA, USA., Hershman DL; Columbia University Irving Medical Center, New York, NY, USA., Neuhouser ML; Fred Hutchinson Cancer Center, Seattle, WA, USA., Arun B; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kukafka R; Columbia University Irving Medical Center, New York, NY, USA.

المصدر: Contemporary clinical trials [Contemp Clin Trials] 2024 Jul; Vol. 142, pp. 107564. Date of Electronic Publication: 2024 May 03.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial Protocol

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/prevention & control , Chemoprevention*/methods, Humans ; Female ; Patient Education as Topic/methods ; Decision Support Techniques ; Middle Aged ; Adult ; Decision Making ; Health Knowledge, Attitudes, Practice ; Risk Reduction Behavior ; Research Design ; Estrogen Antagonists/therapeutic use ; Estrogen Antagonists/administration & dosage ; Patient Reported Outcome Measures

المؤلفون: Hamza S; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia., Garanina EE; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia., Alsaadi M; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia., Khaiboullina SF; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia., Tezcan G; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.; Department of Fundamental Sciences, Faculty of Dentistry, Bursa Uludag University, Bursa 16059, Turkey.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 02; Vol. 24 (5). Date of Electronic Publication: 2023 Mar 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/metabolism , Breast Neoplasms*/pathology , NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism , Tamoxifen*/pharmacology , Estrogen Receptor alpha*/antagonists & inhibitors , Estrogen Receptor alpha*/metabolism , Estrogen Antagonists*/pharmacology, Female ; Humans ; Adenosine Triphosphate/metabolism ; Interleukin-8/metabolism ; Lipopolysaccharides ; MCF-7 Cells ; Receptors, Progesterone/antagonists & inhibitors ; Receptor, ErbB-2/antagonists & inhibitors

المؤلفون: Achounna AS; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico., Ordaz-Rosado D; Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico., García-Quiroz J; Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico., Morales-Guadarrama G; Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico., Milo-Rocha E; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico., Larrea F; Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico., Díaz L; Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico., García-Becerra R; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.; Programa de Investigación de Cáncer de Mama, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 09; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism, Calcitriol/*analogs & derivatives, Humans ; Female ; Lapatinib/pharmacology ; Lapatinib/therapeutic use ; Calcitriol/pharmacology ; Estrogen Receptor alpha/genetics ; Estrogen Receptor alpha/metabolism ; Estrogen Receptor Modulators/pharmacology ; Proto-Oncogene Proteins c-akt/metabolism ; Receptor, ErbB-2/metabolism ; Estrogen Antagonists/therapeutic use ; Cell Line, Tumor